ME/CFS Severely Ill, Big Data Study
The ME/CFS Severely Ill, Big Data Study, led by Ronald Davis, will conduct a comprehensive, “Big Data” analysis on severely ill ME/CFS patients with the goal of finding sensitive and distinctive molecular biomarker(s).
Phase One - comprehensive testing[edit | edit source]
The first phase of the trial includes a very wide array of biological tests which have been defined and published.
...comprehensive/extensive testing of severely ill patients. By thoroughly checking blood, urine, and other body products, we expect to find biological abnormalities that could explain the debilitating symptoms. We don’t want to miss anything. So we’re doing it completely the first time.
In July 2016 it was announced that sample collection was complete.